- Home
- ASTI vs ENSC Comparison
ASTI vs ENSC Comparison
Compare ASTI & ENSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASTI
- ENSC
- Stock Information
- Founded
- ASTI 2005
- ENSC 2003
- Country
- ASTI United States
- ENSC United States
- Employees
- ASTI N/A
- ENSC N/A
- Industry
- ASTI Semiconductors
- ENSC Biotechnology: Pharmaceutical Preparations
- Sector
- ASTI Technology
- ENSC Health Care
- Exchange
- ASTI Nasdaq
- ENSC Nasdaq
- Market Cap
- ASTI 3.1M
- ENSC 2.9M
- IPO Year
- ASTI N/A
- ENSC N/A
- Fundamental
- Price
- ASTI $1.68
- ENSC $3.29
- Analyst Decision
- ASTI
- ENSC
- Analyst Count
- ASTI 0
- ENSC 0
- Target Price
- ASTI N/A
- ENSC N/A
- AVG Volume (30 Days)
- ASTI 53.6K
- ENSC 4.9M
- Earning Date
- ASTI 05-08-2025
- ENSC 05-12-2025
- Dividend Yield
- ASTI N/A
- ENSC N/A
- EPS Growth
- ASTI N/A
- ENSC N/A
- EPS
- ASTI N/A
- ENSC N/A
- Revenue
- ASTI $41,893.00
- ENSC $5,210,031.00
- Revenue This Year
- ASTI N/A
- ENSC N/A
- Revenue Next Year
- ASTI N/A
- ENSC N/A
- P/E Ratio
- ASTI N/A
- ENSC N/A
- Revenue Growth
- ASTI N/A
- ENSC 133.58
- 52 Week Low
- ASTI $1.17
- ENSC $1.62
- 52 Week High
- ASTI $34.00
- ENSC $14.67
- Technical
- Relative Strength Index (RSI)
- ASTI 58.20
- ENSC 55.92
- Support Level
- ASTI $1.30
- ENSC $3.02
- Resistance Level
- ASTI $1.70
- ENSC $4.85
- Average True Range (ATR)
- ASTI 0.13
- ENSC 0.40
- MACD
- ASTI 0.06
- ENSC 0.27
- Stochastic Oscillator
- ASTI 96.23
- ENSC 51.70
About ASTI Ascent Solar Technologies Inc.
Ascent Solar Technologies Inc is engaged in the manufacturing and selling of photovoltaic products (PV) solar modules that are flexible, durable, and possess attractive power-to-weight and power-to-area performance. The company is integrating its PV products into scalable and high-value markets such as agrivoltaics, aerospace, satellites, near-earth orbiting vehicles, and fixed-wing unmanned aerial vehicles (UAV). Ascent is also working to expand its portable solar chargers, such as the XD-12. The company markets and sells its products through OEMs, system integrators, distributors, retailers, and e-commerce companies.
About ENSC Ensysce Biosciences Inc.
Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.